Will Jewish Voters Stop Voting For The Democrats Who Want To Kill Them?
Is Biden Serious With His Victory Lap on 'National Security'?
Someone Has to Be the Adult in the Room: Clear the Quad and...
Our Gallows Hill — The Latest Trump Witch Trial
Adding to the Title IX Law
‘Hush Money’ Case Against Trump Is Bad On The Law and On the...
Israel-Hamas War: Has Hamas Bet Correctly?
Stop the 'Emergency Spending' Charade Already
Joe Biden’s Hitler Problem
Universities of America You Are Directly Responsible for the Rise of Jew Hatred...
The 'Belongers', Part II
Banning TikTok a Blow to Free Speech
Human Dreck
Border Crisis Solution - Forget Biden and Speaker Johnson
NPR Whistleblower Highlights Everything Wrong With Journalism Today
Tipsheet

The CDC Director Just Gave Us an Updated Vaccine Timeline

AP Photo/Alex Brandon

We've brought you a lot of exciting vaccine news these past few weeks. And there's more of it on Tuesday. Center for Disease Control Director Robert Redfield said Americans should expect a vaccine to be rolled out very, very soon. He predicted the second week of December.

Advertisement

The next question then is, who will be receiving the first doses. He answered that too.

In an interview with Fox News anchor Dana Perino, Redfield shared that the first groups to get the vaccine will probably be "nursing home residents and then some combination of health care providers and individuals at high risk for a poor outcome."

"I do think we'll have about 40 million doses of vaccine before the end of the...year," Redfield continued. "That's enough to vaccinate 20 million people. But then it will continue through January and February and hopefully by March we'll start to see vaccine available for the general public."

Advertisement

Pfizer, who vaccine its been developing with BioNTech has produced a 95 percent efficacy rate, requested an emergency authorization from the FDA. A second vaccine candidate being produced by Moderna isn't too far behind, reporting a 94 percent effectiveness. And then a third, developed by AstraZeneca, is up to 90 percent effective.

The FDA has reportedly scheduled a meeting for Dec. 10 with its Vaccines and Related Biological Products Advisory Committee to discuss Pfizer's request.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement